Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- ISA Associates, Inc.
- Study ID
- NCT07011836
- Status
- Recruiting
Conditions
- Uterine Cervical Neoplasms
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- mNav Interactive Video + Navigator — BEHAVIORALA personalized, video-based tool paired with navigator support to address individual screening barriers.
- Educational Video — BEHAVIORALA culturally tailored cervical cancer education video without additional support or tailoring.
Study Details
The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African American women who are currently overdue for screening. The main questions it aims to answer are: Can an interactive video navigation tool (mNav), when paired with in-person navigation, improve screening adherence compared to a standard educational video alone? Does the intervention improve knowledge, reduce barriers, and increase intentions to get screened? Researchers will compare participants who receive both the interactive video (guided by an on-screen navigator) and in-person navigation to those who receive only a standard educational video to see if the tailored support increases screening rates. Participants will: Complete two phone surveys (one at the beginning and one six months later) Be randomly assigned to one of two groups: One group will receive an interactive video experience tailored to their concerns plus support from an in-person navigator The other group will receive a standard educational video designed for African American women Have their clinic records reviewed six months later to check for cervical cancer screening completion
Key Dates
- Start date
- Jul 1, 2025
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 288 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Intervention GroupParticipants use an interactive, personalized video-based navigation tool (mNav) and receive navigator support.
- Active Comparator: Education Control GroupParticipants view a general cervical cancer education video made for Black women, without personalized content or navigator support.
Primary Outcome Measure
Completion of Cervical Cancer Screening [ Time Frame: Within 6 months of enrollment ]
Central Contacts
- Douglas Billings, PhD7037390882
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Family and Medical Counseling Service, Inc. | Washington D.C. | District of Columbia | 20020 | |
| ISA Associates | Arlington | Virginia | 22203 |
Find similar trials in Washington D.C., DC
Related Studies
- A Study of Sigvotatug Vedotin in Advanced Solid TumorsPHASE1 · Recruiting · Seagen, a wholly owned subsidiary of Pfizer · Anchorage, Alaska
- A Study of LY4170156 in Participants With Selected Advanced Solid TumorsPHASE1 · Recruiting · Eli Lilly and Company · Scottsdale, Arizona
- Human Papillomavirus (HPV) Self-Sampling Options to Promote EquityNot Yet Recruiting · University of Arizona · Tucson, Arizona